A multicentre, double-blind, randomised, controlled phase II/III study to evaluate the efficacy and safety of the new wound healing solution Diperoxochloric acid (DPOCl, DermaPro) in patients with venous leg ulcer (ulcus cruris)

Trial Profile

A multicentre, double-blind, randomised, controlled phase II/III study to evaluate the efficacy and safety of the new wound healing solution Diperoxochloric acid (DPOCl, DermaPro) in patients with venous leg ulcer (ulcus cruris)

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Diperoxochloric acid (Primary)
  • Indications Leg ulcer
  • Focus Registrational; Therapeutic Use
  • Sponsors Dermatools
  • Most Recent Events

    • 10 Aug 2017 According to a CytoTools AG Media Release, this trial was terminated because the reanalysis of the batch of active substance used, due to a production error, was only 50 % of the concentration prescribed by DermaTools in the specification for the trial.
    • 12 May 2015 New trial record
    • 04 Mar 2015 Intermediate results of this trial are expected in the second quarter of 2015, according to a CytoTools media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top